Table 1 Patient characteristics
Variable | Group A | Group B | P |
|---|---|---|---|
No. of patients | 21 | 28 | |
Age (years), median (IQR) | 56 (45–68) | 60 (48–72) | 0.3 |
Male, n (%) | 15 (71%) | 17 (61%) | 0.4 |
BMI, kg/m, median (IQR) | 23 (19–28) | 24 (21–28) | 0.4 |
CCI, median (IQR) | 2 (1–3) | 1 (0–2) | 0.6 |
Clinical tumor size (cm), median (IQR) | 3.2 (2.1–4.3) | 3.3 (2.3–4.2) | 0.14 |
R.E.N.A.L. score, median (IQR) | 10 (8–12) | 10 (8–11) | 0.89 |
Tumor growth pattern (%) | 0.20 | ||
Renal hilar tumor | 15 (71) | 15 (53) | 0.19 |
Endophytic | 6 (29) | 13 (47) | 0.21 |
Warm ischemia time (min), median (IQR) | 21 (16–25) | 26 (21–28) | 0.003 |
Tumor resection time (min), median (IQR) | 9 (6–13) | 13 (10–16) | 0.002 |
Suturing time (min), median (IQR) | 11 (8–15) | 16 (11–18) | 0.001 |
EBL (mL), median (IQR) | 129 (100–200) | 160 (120–240) | 0.04 |
Operative time (min), median (IQR) | 112 (97–117) | 115 (103–128) | 0.06 |
Pathologic tumor stage (%) | 0.23 | ||
pT1a | 12 (73) | 21 (65) | |
PT1b | 9 (27) | 7 (35) | |
Positive margins (%) | 0 (0) | 1 (2) | 0.4 |